Filters

Hepatitis C virus Core NS3 + NS4 Positive Controlfor Western Blot

Hepatitis C virus Core NS3 + NS4 Positive Controlfor Western Blot size: 100 µg 264

Supplier FABGEN
Price 264
Size 100 µg
Vial descriptionpurified Hepatitis C virus Core NS3 + NS4 Positive Control
Antibody's or peptide concentrationug/ml in stabilization buffer
Raised insterile environment
Reactivityspecific antigen
Immunogensee msds
Antigen or peptideHepatitis C virus Core NS3 + NS4
Original nameHepatitis C virus Core NS3 + NS4 Positive Control
PhosphorylationNon phosphorylated
Epitopespecific sequence
TypePositive Control
Antibody's relevanceWB
Antibody's applicationWestern Blot
Storage conditions-20⁰C for long term storage
Genbank numbersee ncbi
Protein numberQ81588
Test PVDF is more advised, The best detection method is using enhanced chemiluminescence or ECL, Western Blot can be performed on tissues and cell extracts to determine the proteins present in your sample after PAGE electrophoresis and transfer on PVDF or Nitrocellulose
Description 2, 3, 4, 5 are used for antibody production to make diagnostic poly or monoclonal antibodies, Depending on the cause, Hepatitis may occur , Hepatitis , Positive controls are the same as the target vector or antibody or protein and can be spiked to the sample before the analysis starts, and , and , b, but can lead to , c, d, e recombinant surface viral antigens to genotype 1, hepatitis can manifest either as an acute or as a chronic disease,  ,  , (a yellow discoloration of the , Hepatitis a, cells , conjunctiva , fatigue, in the , inflammatory , is a disease of the liver characterized by the presence of , jaundice , mucous membranes, of the eyes), of the organ, poor appetite, skin, tissue , without symptoms
Grouppositif
Gene targetHepatitis C virus Core NS3 + NS4 Controlfor
Short nameHepatitis C virus Core NS3 + NS4 Positive Controlfor Blot
Technique western Blots, Western Blot
Alternative nameHepatitis C virus Core NS3 and NS4 Positive Controlfor Western Blot
Alternative techniquecontrols

Subscribe to our Newsletter